Luke Bashford and colleagues attract major investment to bolster UK clinical capability in neurotechnology

20 November 2026

Many congratulations to MRC CoRE RND Leadership Team member Dr Luke Bashford and colleagues at the MRC CoRE RND’s partner The NHS National Centre for Neurotechnology and Neurorestoration (NCNN) on the announcement of a £6.2 million investment to accelerate the clinical use of innovative neurotechnology.

The investment will boost the NCNN’s work to develop and deploy the latest neurotechnology, enhancing the UK’s research, innovation and regulatory ecosystem supporting medical device development.

Luke commented “This funding will allow the expansion of dedicated facilities and will empower highly skilled colleagues to deliver neurotechnology clinical studies within the National Health Service. This capacity will benefit the entire UK ecosystem, and in particular support the ambitions of the MRC CoRE RND”.

MRC CoRE RND Director Peter Magill commented “We are thrilled for Luke and our partners at the NCNN. This investment resonates well with our Challenge, and we look forward to continuing working with the NCNN to galvanise the adoption of advanced medical devices for treating people affected by brain conditions.”

Image
portrait photo of Luke Bashford

Similar Content